BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

BAK-free DuoTrav travoprost/timolol regulatory update

Alcon disclosed in its 4Q10 earnings that it submitted an MAA to the European Medicines Agency (EMA) for a benzalkonium chloride (BAK)-free formulation of DuoTrav travoprost/timolol ophthalmic...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >